Brucellosis Vaccine Challegne Project: 2019 Interim Assessment

This assessment reflects the experience of competitors in the Brucellosis Vaccine Challenge Project from mid-2018 to mid-2019

Abstract

This assessment by External Evaluator Abt Associates reflects the experience of competitors in the Brucellosis Vaccine Challenge Project from mid-2018 to mid-2019. Most competitors reported that the competition had helped advance their B. melitensis vaccine R&D. However, many of them anticipated challenges completing the safety and efficacy trials due to resource constraints.

This work is part of the AgResults programme

Citation

Conrad, Abigail, Marius Meijerink, and Tulika Narayan (2020). AgResults Evaluation: Brucellosis Vaccine Challenge Project – 2019 Interim Assessment. Rockville, Maryland: Abt Associates.

Brucellosis Vaccine Challegne Project: 2019 Interim Assessment

Updates to this page

Published 15 May 2020